Novo Nordisk investing $117.4M in manufacturing site in Denmark

7th February 2020 Uncategorised 0

Novo Nordisk’s site in Kalundborg, Denmark, already manufactures about half of the world’s insulin, but with a DKK 800 million makeover the site will be able to produce even more insulin and other products. 

More: Novo Nordisk investing 7.4M in manufacturing site in Denmark
Source: fierce